Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis

Clin Nucl Med. 2007 Feb;32(2):114-6. doi: 10.1097/01.rlu.0000252216.68848.d7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Positron-Emission Tomography*
  • Radiopharmaceuticals
  • Sarcoidosis, Pulmonary / drug therapy*

Substances

  • Adrenal Cortex Hormones
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18